LON:HLN Haleon (HLN) Share Price, News & Analysis GBX 390.40 +8.50 (+2.23%) As of 12:41 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About Haleon Stock (LON:HLN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Haleon alerts:Sign Up Key Stats Today's Range 383.70▼ 391.2550-Day Range 367.94▼ 41552-Week Range 319.20▼ 417.70Volume92.02 million shsAverage Volume28.83 million shsMarket Capitalization£35.24 billionP/E Ratio32.83Dividend Yield1.54%Price TargetGBX 420Consensus RatingBuy Company OverviewHaleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other. Within these categories, there are long standing-brands – such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, paradontax and Centrum, which are used and trusted by millions of consumers around the world. These brands are built on trusted science, innovation and deep human understanding.Read More… Remove Ads Haleon Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks15th Percentile Overall ScoreHLN MarketRank™: Haleon scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingBuy Consensus RatingHaleon has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageHaleon has only been the subject of 1 research reports in the past 90 days.Read more about Haleon's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Haleon is 32.83, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.56.Price to Earnings Ratio vs. SectorThe P/E ratio of Haleon is 32.83, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.14.Price to Earnings Growth RatioHaleon has a PEG Ratio of 1.49. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHaleon has a P/B Ratio of 2.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for HLN. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldHaleon has a dividend yield of 0.02%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthHaleon does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Haleon is 50.46%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Haleon's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for HLN. News and Social Media2.9 / 5News Sentiment0.29 News SentimentHaleon has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Haleon this week, compared to 1 article on an average week.Search Interest7 people have searched for HLN on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days.MarketBeat Follows1 people have added Haleon to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Haleon insiders have not sold or bought any company stock.Percentage Held by Insiders10.74% of the stock of Haleon is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions43.88% of the stock of Haleon is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Haleon's insider trading history. Receive HLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter. Email Address HLN Stock News HeadlinesHaleon slips Monday, underperforms marketMarch 24, 2025 | marketwatch.comNotable healthcare headlines for the week: Pfizer, Sanofi, Sarepta Therapeutics and Medtronic in focusMarch 23, 2025 | msn.comPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.March 28, 2025 | Brownstone Research (Ad)Kepler Capital Reaffirms Their Buy Rating on Haleon PLC (HLN)March 22, 2025 | markets.businessinsider.comPfizer to sell entire Haleon stakeMarch 18, 2025 | msn.comHaleon slips Wednesday, underperforms marketMarch 12, 2025 | marketwatch.comHaleon slides Wednesday, underperforms marketMarch 5, 2025 | marketwatch.comHaleon downgraded to Hold from Buy at HSBCMarch 5, 2025 | markets.businessinsider.comSee More Headlines HLN Stock Analysis - Frequently Asked Questions How have HLN shares performed this year? Haleon's stock was trading at GBX 377.40 at the start of the year. Since then, HLN stock has increased by 3.4% and is now trading at GBX 390.40. View the best growth stocks for 2025 here. How were Haleon's earnings last quarter? Haleon plc (LON:HLN) announced its quarterly earnings data on Friday, February, 28th. The company reported $15.80 earnings per share (EPS) for the quarter. Haleon had a trailing twelve-month return on equity of 6.54% and a net margin of 9.66%. How do I buy shares of Haleon? Shares of HLN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Haleon own? Based on aggregate information from My MarketBeat watchlists, some other companies that Haleon investors own include GSK (GSK), Micron Technology (MU), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Meta Platforms (META) and Unilever (ULVR). Company Calendar Last Earnings2/28/2025Today3/28/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryConsumer Goods Current SymbolLON:HLN CIKN/A Webwww.haleon.com Phone44 1932 822000FaxN/AEmployees25,408Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 420 High Stock Price TargetGBX 457 Low Stock Price TargetGBX 383 Potential Upside/Downside+8.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 11.89 Trailing P/E Ratio32.61 Forward P/E Ratio19.88 P/E Growth1.49Net Income£1.07 billion Net Margins9.66% Pretax MarginN/A Return on Equity6.54% Return on Assets4.45% Debt Debt-to-Equity Ratio53.36 Current Ratio0.84 Quick Ratio0.93 Sales & Book Value Annual Sales£11.07 billion Price / Sales3.16 Cash FlowGBX 17.66 per share Price / Cash Flow21.95 Book ValueGBX 182.02 per share Price / Book2.13Miscellaneous Outstanding Shares9,025,597,051Free FloatN/AMarket Cap£35.00 billion OptionableNot Optionable Beta0.19 The 10 Best Stocks to Own: Spring 2025Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.Get This Free Report This page (LON:HLN) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump’s Treasure Map [Pic inside]We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haleon plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Haleon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.